News Releases

Fred Hutchinson Cancer Research Center Named as Core Operations Center for Worldwide HIV Vaccine Trials Network

ADVISORY - PRESS BRIEFING

The National Institute of Allergy and Infectious Diseases announced today the formal establishment of a worldwide HIV Vaccine Trials Network (HVTN). The network creates a coordinated, global framework in which to conduct clinical HIV vaccine research.

The Fred Hutchinson Cancer Research Center will have three roles in the HVTN: Dr. Larry Corey will head the Core Operations Center, the network's Statistical and Data Management Center will be led by Dr. Steve Self, both to be located at the Hutchinson Center. Dr. Julie McElrath with head the domestic site at the Hutchinson Center, one of nine domestic sites nationwide.

DRS. LAWRENCE COREY AND JULIE MCELRATH WILL BE AVAILABLE TO DISCUSS THE NETWORK 2-3 P.M. THURSDAY, MAY 25, 2000

FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVE. N.
PELTON AUDITORIUM

Lawrence Corey, M.D., head of infectious diseases, Fred Hutchinson Cancer Research Center, and professor of medicine and laboratory medicine, University of Washington

Julie McElrath, M.D., Ph. D., associate head of infectious diseases, Fred Hutchinson Cancer Research Center, and associate professor of medicine, University of Washington

Steven Self, Ph.D., head of biostatistics, Fred Hutchinson Cancer Research Center

 

# # #

The Fred Hutchinson Cancer Research Center is an independent, nonprofit research institution dedicated to the development and advancement of biomedical technology to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, the Center's four scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Hutchinson Center is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. For more information, visit the Center's Web site at <www.fhcrc.org>.